Table of Contents

2019-2024 Global Antacid Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Antacid Consumption 2014-2024
  • 2.1.2 Antacid Consumption CAGR by Region
• 2.2 Antacid Segment by Type
  • 2.2.1 Proton Pump Inhibitor
  • 2.2.2 H2 Antagonist
  • 2.2.3 Acid Neutralizers
• 2.3 Antacid Consumption by Type
  • 2.3.1 Global Antacid Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Antacid Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Antacid Sale Price by Type (2014-2019)
• 2.4 Antacid Segment by Application
  • 2.4.1 OTC Drug
  • 2.4.2 Rx Drug
• 2.5 Antacid Consumption by Application
  • 2.5.1 Global Antacid Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Antacid Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Antacid Sale Price by Application (2014-2019)

3 Global Antacid by Players

• 3.1 Global Antacid Sales Market Share by Players
  • 3.1.1 Global Antacid Sales by Players (2017-2019)
  • 3.1.2 Global Antacid Sales Market Share by Players (2017-2019)
• 3.2 Global Antacid Revenue Market Share by Players
  • 3.2.1 Global Antacid Revenue by Players (2017-2019)
  • 3.2.2 Global Antacid Revenue Market Share by Players (2017-2019)
• 3.3 Global Antacid Sale Price by Players
• 3.4 Global Antacid Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Antacid Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Antacid Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Antacid by Regions

• 4.1 Antacid by Regions
  • 4.1.1 Global Antacid Consumption by Regions
  • 4.1.2 Global Antacid Value by Regions
• 4.2 Americas Antacid Consumption Growth
• 4.3 APAC Antacid Consumption Growth
• 4.4 Europe Antacid Consumption Growth
• 4.5 Middle East & Africa Antacid Consumption Growth

5 Americas

• 5.1 Americas Antacid Consumption by Countries
  • 5.1.1 Americas Antacid Consumption by Countries (2014-2019)
  • 5.1.2 Americas Antacid Value by Countries (2014-2019)
• 5.2 Americas Antacid Consumption by Type
• 5.3 Americas Antacid Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Antacid Consumption by Countries
  • 6.1.1 APAC Antacid Consumption by Countries (2014-2019)
  • 6.1.2 APAC Antacid Value by Countries (2014-2019)
• 6.2 APAC Antacid Consumption by Type
• 6.3 APAC Antacid Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Antacid by Countries
  • 7.1.1 Europe Antacid Consumption by Countries (2014-2019)
  • 7.1.2 Europe Antacid Value by Countries (2014-2019)
• 7.2 Europe Antacid Consumption by Type
• 7.3 Europe Antacid Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Antacid by Countries
  • 8.1.1 Middle East & Africa Antacid Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Antacid Value by Countries (2014-2019)
• 8.2 Middle East & Africa Antacid Consumption by Type
• 8.3 Middle East & Africa Antacid Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Antacid Distributors
• 10.3 Antacid Customer

11 Global Antacid Market Forecast

• 11.1 Global Antacid Consumption Forecast (2019-2024)
• 11.2 Global Antacid Forecast by Regions
  • 11.2.1 Global Antacid Forecast by Regions (2019-2024)
  • 11.2.2 Global Antacid Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Antacid Forecast by Type
• 11.8 Global Antacid Forecast by Application

12 Key Players Analysis

• 12.1 AstraZeneca
  • 12.1.1 Company Details
  • 12.1.2 Antacid Product Offered
  • 12.1.3 AstraZeneca Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 AstraZeneca News
• 12.2 Takeda Pharmaceutical
  • 12.2.1 Company Details
  • 12.2.2 Antacid Product Offered
  • 12.2.3 Takeda Pharmaceutical Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Takeda Pharmaceutical News
• 12.3 Pfizer
  • 12.3.1 Company Details
  • 12.3.2 Antacid Product Offered
  • 12.3.3 Pfizer Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Pfizer News
• 12.4 Reckitt Benckiser
  • 12.4.1 Company Details
  • 12.4.2 Antacid Product Offered
  • 12.4.3 Reckitt Benckiser Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Reckitt Benckiser News
• 12.5 Bayer
  • 12.5.1 Company Details
  • 12.5.2 Antacid Product Offered
  • 12.5.3 Bayer Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Bayer News
• 12.6 Procter＆Gamble
  • 12.6.1 Company Details
  • 12.6.2 Antacid Product Offered
  • 12.6.3 Procter＆Gamble Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Procter＆Gamble News
• 12.7 GlaxoSmithKline
  • 12.7.1 Company Details
  • 12.7.2 Antacid Product Offered
  • 12.7.3 GlaxoSmithKline Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 GlaxoSmithKline News
• 12.8 Johnson＆Johnson
  • 12.8.1 Company Details
  • 12.8.2 Antacid Product Offered
  • 12.8.3 Johnson＆Johnson Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Johnson＆Johnson News
• 12.9 CONBA
  • 12.9.1 Company Details
  • 12.9.2 Antacid Product Offered
  • 12.9.3 CONBA Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 CONBA News
• 12.10 Xiuzheng Pharma
  • 12.10.1 Company Details
  • 12.10.2 Antacid Product Offered
  • 12.10.3 Xiuzheng Pharma Antacid Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Xiuzheng Pharma News
• 12.11 Sanofi
• 12.12 Bausch Health
• 12.13 CR SANJIU
• 12.14 Reddy's Laboratories

13 Research Findings and Conclusion

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.
The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Antacid includes Proton Pump Inhibitor, H2 Antagonist and Acid Neutralizers, and the proportion of Proton Pump Inhibitor in 2017 is about 39%.

According to this study, over the next five years the Antacid market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 6300 million by 2024, from US$ 6120 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antacid business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antacid market by product type, application, key manufacturers and key regions and countries.

This study considers the Antacid value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
OTC Drug
Rx Drug

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antacid consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antacid market by identifying its various subsegments.
Focuses on the key global Antacid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antacid with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antacid submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.